Greenleaf Trust’s Amarin Corp AMRN Stock Holding History

Greenleaf Trust’s Portfolio AMRN Stock Details AMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-693	Closed	-$21K	–	712
2022 Q2	$21K	Buy	+693	New	+$29.9K	﹤0.01%	713

Other funds holding AMRN

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Greenleaf Trust's AMRN Position: Q3 2022 in Review

Greenleaf Trust sold out of Amarin Corp (AMRN) in Q3 2022, closing a stake of 693 shares — an estimated $21K sold.

Greenleaf Trust first reported a position in AMRN in Q2 2022 and held it in 1 quarter. The position peaked at $21K in Q2 2022. 204 funds tracked by Wall St. Rank hold AMRN as of Q3 2022.

Greenleaf Trust reported no remaining Amarin Corp position as of Q3 2022 after selling out during the quarter.
Greenleaf Trust sold 693 Amarin Corp shares in Q3 2022, an estimated $21K.
Greenleaf Trust first reported a position in Amarin Corp in Q2 2022 and held it in 1 quarter.
Greenleaf Trust's Amarin Corp position peaked at $21K in Q2 2022.
204 funds tracked by Wall St. Rank held Amarin Corp as of Q3 2022.

Based on Greenleaf Trust's 13F filing for Q3 2022, filed 10 Nov 2022.